Cargando…

Clinical Application of Tumor Vascular Disrupting Therapy: A Systematic Review and Meta-Analysis

PURPOSE: The occurrence, progression, invasion and metastasis of tumors depend on a tumor vascular network. Vascular disrupting agents (VDAs) are a new class of drugs targeting the tumor vasculature, by blocking the existing tumor blood vessels. However, there is no clear consensus on the clinical e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsang, Wen, Gan, Lu, Zhang, Zhikun, Li, Tong, Luo, Yiqun, Zhong, Liping, Huang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542587/ https://www.ncbi.nlm.nih.gov/pubmed/34707366 http://dx.doi.org/10.2147/OTT.S321658

Ejemplares similares

Aptamer‐based biosensors and application in tumor theranostics
por: Mo, Tong, et al.
Publicado: (2021)

Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy
por: Hua, Jianfeng, et al.
Publicado: (2021)

Generation of αGal-enhanced bifunctional tumor vaccine
por: He, Jian, et al.
Publicado: (2022)

Disruption of Vascular Barriers in Tumors and in the Brain
por: McDannold, Nathan
Publicado: (2015)

Signal Amplification-Based Biosensors and Application in RNA Tumor Markers
por: Li, Haiping, et al.
Publicado: (2023)

Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption
por: Hong, Sheng, et al.
Publicado: (2020)

BSA-Coated Gold Nanorods for NIR-II Photothermal Therapy
por: Zhao, Shubi, et al.
Publicado: (2021)

Tumor vascular disruption using various radiation types
por: Bevelacqua, JJ
Publicado: (2014)

Enhancing Nanoparticle Accumulation and Retention in Desmoplastic Tumors via Vascular Disruption for Internal Radiation Therapy
por: Satterlee, Andrew B., et al.
Publicado: (2017)

(210)Po microsphere radiological design for tumor vascular disruption
por: Bevelacqua, JJ
Publicado: (2015)

Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions
por: Liang, Wenjie, et al.
Publicado: (2016)

Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption
por: Virani, Needa A., et al.
Publicado: (2020)

Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors
por: Griffin, Robert J., et al.
Publicado: (2012)

Improving Nanoparticle Penetration in Tumors by Vascular Disruption with Acoustic Droplet Vaporization
por: Ho, Yi-Ju, et al.
Publicado: (2016)

Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo
por: Zhong, Liping, et al.
Publicado: (2021)

Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis
por: Zhong, Yi-Ming, et al.
Publicado: (2022)

Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
por: Zhong, Liping, et al.
Publicado: (2021)

Application of Biomedical Microspheres in Wound Healing
por: Yang, Caihong, et al.
Publicado: (2023)

Gut-Spleen Axis: Microbiota via Vascular and Immune Pathways Improve Busulfan-Induced Spleen Disruption
por: Fang, Hanhan, et al.
Publicado: (2022)

Vascular disrupting agents in clinical development
por: Hinnen, P, et al.
Publicado: (2007)

Associations Between Different Cortisol Measures and Adiposity in Children: A Systematic Review and Meta-Analysis
por: Ma, Lu, et al.
Publicado: (2022)

ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
por: Bähr, Oliver, et al.
Publicado: (2017)

Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis
por: Liu, Yong, et al.
Publicado: (2021)

Monitoring of tumor vascular normalization: the key points from basic research to clinical application
por: Li, Wei, et al.
Publicado: (2018)

Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Effectiveness and Safety of Acupuncture for Vascular Cognitive Impairment: A Systematic Review and Meta-Analysis
por: Su, Xin-Tong, et al.
Publicado: (2021)

KML001 Displays Vascular Disrupting Properties and Irinotecan Combined Antitumor Activities in a Murine Tumor Model
por: Moon, Chang Hoon, et al.
Publicado: (2013)

Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis
por: Geeganage, Chamila, et al.
Publicado: (2010)

Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3
por: Klover, Peter J, et al.
Publicado: (2017)

Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents
por: Horsman, Michael R., et al.
Publicado: (2020)

Efficacy of acupuncture and pharmacological therapies for vascular cognitive impairment with no dementia: a network meta-analysis
por: Li, Ruiyu, et al.
Publicado: (2023)

Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101
por: Bao, Xin, et al.
Publicado: (2021)

A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
por: Crielaard, Bart J, et al.
Publicado: (2011)

Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents
por: Zhang, Dongjian, et al.
Publicado: (2018)

Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis
por: Tang, Lanhua, et al.
Publicado: (2013)

A light-controlled multi-step drug release nanosystem targeting tumor hypoxia for synergistic cancer therapy
por: Zhang, Bin, et al.
Publicado: (2021)

Alternative Vascularization Mechanisms in Tumor Resistance to Therapy
por: Belotti, Dorina, et al.
Publicado: (2021)

DDX24 Mutation Alters NPM1 Phase Behavior and Disrupts Nucleolar Homeostasis in Vascular Malformations
por: Zhang, Haopei, et al.
Publicado: (2023)

Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-Analysis
por: Wang, Jiani, et al.
Publicado: (2022)

Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients
por: Yang, Yong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g4ivujmfrh5vn1iijhrjbrhb5h